Cargando…

Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial

BACKGROUND: Cardiovascular secondary preventive recommendations are often not reached. We investigated whether a nurse-led telephone-based follow-up could improve the implementation of a new guideline within a year after its release. METHODS: In February 2013, a new secondary preventive guideline fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakobsson, Stina, Huber, Daniel, Björklund, Fredrik, Mooe, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851797/
https://www.ncbi.nlm.nih.gov/pubmed/27129980
http://dx.doi.org/10.1186/s12872-016-0252-0
_version_ 1782429863800471552
author Jakobsson, Stina
Huber, Daniel
Björklund, Fredrik
Mooe, Thomas
author_facet Jakobsson, Stina
Huber, Daniel
Björklund, Fredrik
Mooe, Thomas
author_sort Jakobsson, Stina
collection PubMed
description BACKGROUND: Cardiovascular secondary preventive recommendations are often not reached. We investigated whether a nurse-led telephone-based follow-up could improve the implementation of a new guideline within a year after its release. METHODS: In February 2013, a new secondary preventive guideline for diabetic patients was released in the county of Jämtland, Sweden. It included a changed of the low-density lipoprotein cholesterol (LDL-C) target value from <2.5 mmol/L to <1.8 mmol/L. In the Nurse-Based Age-Independent Intervention to Limit Evolution of Disease (NAILED) trial, patients with an acute coronary syndrome, stroke, or transient ischemic attack were randomized to secondary preventive care with nurse-based telephone follow-up (intervention) or usual care (control). Patient data were obtained from the NAILED trial to study the implementation of the new LDL-C guideline by comparing telephone follow-up with usual care. The Mann–Whitney U-test was used for continuous variables, and Person’s χ(2) test was used for categorical variables to assess between-group differences. RESULTS: Out of the 1267 patients that entered the study period, 101 intervention and 100 control patients with diabetes fulfilled the inclusion criteria and completed the study period. Before the guideline change, 96 % of the intervention patients and 70 % of the control patients reached the target LDL-C value (p < 0.001). After the guideline change, the corresponding respective proportions were 65 % and 36 % (p < 0.001). The main reason that intervention patients did not achieve the target LDL-C value was that they received full-dose treatment; for control patients, the main reason was that medication was not adjusted, for an unknown reason. CONCLUSIONS: One year after a change in the cardiovascular secondary preventive guideline, nurse-based telephone follow-up performed better than usual care to implement the new recommendation. TRIAL REGISTRATION: ISRCTN registry; ISRCTN96595458 (date of registration 10 July 2011) and ISRCTN23868518 (date of registration 13 May 2012).
format Online
Article
Text
id pubmed-4851797
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48517972016-05-01 Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial Jakobsson, Stina Huber, Daniel Björklund, Fredrik Mooe, Thomas BMC Cardiovasc Disord Research Article BACKGROUND: Cardiovascular secondary preventive recommendations are often not reached. We investigated whether a nurse-led telephone-based follow-up could improve the implementation of a new guideline within a year after its release. METHODS: In February 2013, a new secondary preventive guideline for diabetic patients was released in the county of Jämtland, Sweden. It included a changed of the low-density lipoprotein cholesterol (LDL-C) target value from <2.5 mmol/L to <1.8 mmol/L. In the Nurse-Based Age-Independent Intervention to Limit Evolution of Disease (NAILED) trial, patients with an acute coronary syndrome, stroke, or transient ischemic attack were randomized to secondary preventive care with nurse-based telephone follow-up (intervention) or usual care (control). Patient data were obtained from the NAILED trial to study the implementation of the new LDL-C guideline by comparing telephone follow-up with usual care. The Mann–Whitney U-test was used for continuous variables, and Person’s χ(2) test was used for categorical variables to assess between-group differences. RESULTS: Out of the 1267 patients that entered the study period, 101 intervention and 100 control patients with diabetes fulfilled the inclusion criteria and completed the study period. Before the guideline change, 96 % of the intervention patients and 70 % of the control patients reached the target LDL-C value (p < 0.001). After the guideline change, the corresponding respective proportions were 65 % and 36 % (p < 0.001). The main reason that intervention patients did not achieve the target LDL-C value was that they received full-dose treatment; for control patients, the main reason was that medication was not adjusted, for an unknown reason. CONCLUSIONS: One year after a change in the cardiovascular secondary preventive guideline, nurse-based telephone follow-up performed better than usual care to implement the new recommendation. TRIAL REGISTRATION: ISRCTN registry; ISRCTN96595458 (date of registration 10 July 2011) and ISRCTN23868518 (date of registration 13 May 2012). BioMed Central 2016-04-30 /pmc/articles/PMC4851797/ /pubmed/27129980 http://dx.doi.org/10.1186/s12872-016-0252-0 Text en © Jakobsson et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Jakobsson, Stina
Huber, Daniel
Björklund, Fredrik
Mooe, Thomas
Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial
title Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial
title_full Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial
title_fullStr Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial
title_full_unstemmed Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial
title_short Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial
title_sort implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851797/
https://www.ncbi.nlm.nih.gov/pubmed/27129980
http://dx.doi.org/10.1186/s12872-016-0252-0
work_keys_str_mv AT jakobssonstina implementationofanewguidelineincardiovascularsecondarypreventivecaresubanalysisofarandomizedcontrolledtrial
AT huberdaniel implementationofanewguidelineincardiovascularsecondarypreventivecaresubanalysisofarandomizedcontrolledtrial
AT bjorklundfredrik implementationofanewguidelineincardiovascularsecondarypreventivecaresubanalysisofarandomizedcontrolledtrial
AT mooethomas implementationofanewguidelineincardiovascularsecondarypreventivecaresubanalysisofarandomizedcontrolledtrial